Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.2 GBX | +1.80% | +7.40% | -26.11% |
Apr. 30 | Deutsche Bank Starts PZ Cussons Coverage at Buy | MT |
Apr. 30 | Deutsche says buy Barr, Britvic and Fevertree | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.11% | 602M | B- | ||
+13.58% | 143B | B- | ||
+18.09% | 77.23B | A+ | ||
-12.61% | 65.42B | A- | ||
-7.86% | 48.32B | B+ | ||
-4.92% | 39.2B | - | ||
+6.63% | 35.21B | B- | ||
+11.64% | 18.31B | A- | ||
+14.87% | 15.9B | B | ||
-3.09% | 11.4B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PZC Stock
- Ratings PZ Cussons plc